Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-20-045702

SVP, General Counsel and Sec sold 13,274 shares at $20.00 ($265,480)

  • SVP, General Counsel and Sec acquired 13,274 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Colin SVP, General Counsel and Sec 2020-08-05 Option exercise +13,274 $7.50 $99,555 30,399 D
Sandercock Colin SVP, General Counsel and Sec 2020-08-05 Sale −13,274 $20.00 $265,480 17,125 D
Derivatives
Sandercock Colin SVP, General Counsel and Sec 2020-08-05 Option exercise · Stock Option (right to buy) −13,274 130,100 D
Open-market sales · 13,274 sh · avg $20.00 · $265,480
Loading xslF345X03/doc4.xml…